All In MedTech

Device Trial Radar · NCT06585579

The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)

ORIGYNE (MUCO232) - the Effect of Mucogyne® Ovule on Wound Healing

Last checked: Nov 20, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 144 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

144

Planned (sponsor's estimate)

Start

Oct 2024

Primary completion

Aug 2025

Study completion Nov 2025

Sponsor

Lead sponsor
BiocodexNot on our public-company list
Sponsor type
Industry
First posted
Sep 5, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.

Conditions

  • Cervicovaginitis

Interventions

  • Mucogyne OvuleDevice

    In Mucogyne group, patient will receive 2 boxes of Mucogyne® ovule. 24 hours after intervention, the patient will apply Mucogyne® ovule, 1 ovule per day for 10 days, to be repeated as needed (for practices' homogenisation, after the 10th day, it is recommended to apply one ovule every second day, until EOS visit)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To confirm the performance of Mucogyne® ovule in wound healing promotionTime frame: Day 0 to day 21(+10)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Amiens-Picardie

    Amiens, France

  • CHU Besançon

    Besançon, France

  • Hôpital Nord Franche-Comté

    Trévenans, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.